James George Chopas
CIK 1836430 · VP/Chief Accounting Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
33
Lifetime Open-Market Net
-$382.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | VP/Chief Accounting Officer | 8,075 | $41.03 | $331.3K | -$374.9K | 30 | 2026-05-14 |
| Radius Health, Inc. (RDUS) Delisted | Principal Finance Accounting | 6,701 | $30.00 | $201.0K | -$7.7K | 3 | 2021-03-09 |
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-01 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −551 | -$22.7K | EDGAR |
| 2023-02-22 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +3,710 | -$19.5K | EDGAR |
| 2023-01-24 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Tax (F) | −919 | -$47.8K | EDGAR |
| 2023-01-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +9,621 | $0 | EDGAR |
| 2022-10-24 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Tax (F) | −130 | -$7.5K | EDGAR |
| 2022-08-31 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Tax (F) | −558 | -$32.8K | EDGAR |
| 2022-02-07 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +10,657 | $0 | EDGAR |
| 2022-01-25 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +6,974 | $0 | EDGAR |
| 2021-10-27 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +882 | $0 | EDGAR |
| 2021-09-01 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +7,600 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.